Downside Risk · 2026-06-25 · Hospital & Healthcare Services
HCG
Healthcare Global Enterprises Ltd.
Watchlist-worthy setup
Setup readiness
Late Stage
- Pivot Levels
- ₹660.7-667.3
- Support Level
- ₹634.4
- Resistance
- ₹796.8
- Risk Distance
- 4.9% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Constructive setup
Structure shows workable momentum characteristics with selective risks to monitor.
Bullish factors
- Price remains under the 150DMA — longer-term trend repair still needed.
Risk factors
- 6 distribution days recently — institutional selling
- Not in a Stage 2 uptrend (Stage 4)
Overall view
Constructive setup — key momentum and institutional cues are broadly aligned for continued research.
Setup research
HCG — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Building toward the pivot (10% below)
- Volume 1.9× the 50-day average
- Handle formed after the prior advance
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 4 — caution
- Sector Lagging (#40/40) — headwind
- Relative strength Lagging (RS 49)
- Trend strength Weak (ADX 14)
Negatives
This idea is wrong below ₹634.4 (-5.7% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹634.4
- Pivot — failure re-entry below₹664.0
Risk distance
Risk ≈ ₹32.88/share from entry ₹667.3.
Reasons to skip 2
Disqualifiers that apply even if the score looks good.
- 6 distribution days recently — institutional selling
- Not in a Stage 2 uptrend (Stage 4)
Setup metrics Downside Risk
HCG Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest downside risk scan.
Structure
Momentum
Risk
More scanner fields
HCG Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
HCG FAQ Common swing-trading questions
Frequently asked questions about HCG
What are the screener observations for HCG?
On Swing Edge's swing-setup framework, Healthcare Global Enterprises Ltd. (HCG) currently grades D — low-quality — likely skip. Building toward the pivot (10% below). Flagged today. This is educational research, not investment advice.
What are HCG's support and resistance levels?
For HCG, near-term support sits around ₹634.4 (the base/stop zone); overhead resistance is around ₹664.0 (the breakout pivot); the next resistance above is ₹796.8. This is educational research, not investment advice.
What is the breakout / pivot level for HCG?
The breakout pivot for HCG is around ₹664.0. Price is about 9.6% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is HCG above its 50-day and 200-day moving averages?
HCG is currently in Stage 4, not a confirmed Stage 2 uptrend, so trend support from the key moving averages is weaker than ideal for a swing entry. This is educational research, not investment advice.
How strong is HCG versus the market (RS rank)?
HCG has a relative strength (RS) rank of 49 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 14, indicating a weak/choppy trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.